4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095017
Director acquired 500 shares (grant or award)
- Director acquired 4,021,300 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Duey Marc Director | 2022-08-23 | Conversion | +4,009,690 | 4,167,589 | D: show line 1 in the form | ||
| Duey Marc Director | 2023-08-23 | Grant or award | +500 | 208,878 | D: show line 2 in the form | ||
| Duey Marc Director | 2022-08-23 | Conversion | +11,610 | 602 | I: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Duey Marc Director | 2022-08-23 | Conversion · Series A Non-Voting Convertible Preferred Stock | −400,969 | 0 | D: show line 4 in the form | ||
| Duey Marc Director | 2022-08-23 | Conversion · Series A Non-Voting Convertible Preferred Stock | −1,161 | 0 | I: show line 5 in the form | ||
| Duey Marc Director | 2023-08-23 | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | D: show line 6 in the form |
Loading xslF345X05/tm2324788-4_4seq1.xml…